(5R,6S)-3-(7-Iodomethyl-9-oxo-9H-fluoren-3-yl)-7-oxo-6-((R)-1-triethylsilanyloxy-ethyl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester | 187480-68-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 英文名称: (5R,6S)-3-(7-Iodomethyl-9-oxo-9H-fluoren-3-yl)-7-oxo-6-((R)-1-triethylsilanyloxy-ethyl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester
• CAS: 187480-68-8
• 化学式: C₃₆H₃₇IN₂O₇Si
• 分子量: 764.689
• InChiKey: BSKPTLXVNHNZRM-JJDYZBRISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.84
• 重原子数：
  47.0
• 可旋转键数：
  12.0
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  116.05
• 氢给体数：
  0.0
• 氢受体数：
  7.0

反应信息

• 作为反应物：
  描述：

  (5R,6S)-3-(7-Iodomethyl-9-oxo-9H-fluoren-3-yl)-7-oxo-6-((R)-1-triethylsilanyloxy-ethyl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester 在 盐酸 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 生成
  参考文献：
  名称：

  Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties

  摘要：

  The synthesis and biological evaluation of a series of dicationic-substituted 2-fluorenonylcarbapenems is described. This class of compounds showed enhanced water solubility while maintaining potent activity against MRS. Introduction of a beta 1--methyl substituent was found to improve pharmacokinetics. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00567-3
• 作为产物：
  描述：

  (5R,6S)-3-(7-Methanesulfonyloxymethyl-9-oxo-9H-fluoren-3-yl)-7-oxo-6-((R)-1-triethylsilanyloxy-ethyl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester 在 sodium iodide 作用下， 以 丙酮 为溶剂， 生成 (5R,6S)-3-(7-Iodomethyl-9-oxo-9H-fluoren-3-yl)-7-oxo-6-((R)-1-triethylsilanyloxy-ethyl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-nitro-benzyl ester
  参考文献：
  名称：

  Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties

  摘要：

  The synthesis and biological evaluation of a series of dicationic-substituted 2-fluorenonylcarbapenems is described. This class of compounds showed enhanced water solubility while maintaining potent activity against MRS. Introduction of a beta 1--methyl substituent was found to improve pharmacokinetics. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00567-3